C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2001
12/20/2001	WO2001096289A1 Sulfonamide derivatives
12/20/2001	WO2001096285A1 Beta-amino acid nitrile derivatives
12/20/2001	WO2001096283A2 Hiv integrase inhibitors
12/20/2001	WO2001051456A3 Antibacterial agents
12/20/2001	CA2412857A1 Hiv integrase inhibitors
12/20/2001	CA2411811A1 Sulfonamide derivatives
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/19/2001	EP1164128A1 4-Cyanophenyliminoheterocycles
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	CN1327443A Substituted anilides
12/19/2001	CN1327439A Method for preparing a non-crystallizable polyol syrup
12/19/2001	CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001	CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof
12/19/2001	CN1076345C 2,3-diaminopropionic acid derivatives
12/18/2001	US6331640 Diaminopropionic acid derivatives
12/18/2001	US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control
12/18/2001	US6331559 Lipoic acid derivatives and their use in treatment of disease
12/18/2001	US6331542 Protease inhibitors
12/13/2001	WO2001094357A1 Antitumoral compounds
12/13/2001	WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same
12/13/2001	WO2001094306A2 (bis)sulfonamide derivatives
12/13/2001	WO2001094305A1 Sulfonated perfluorovinyl functional monomers
12/13/2001	WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
12/13/2001	US20010051725 Directly from a halomethyl alcohol protected amine derivative and an amine or alkyl carbamate substituted halomethyl alcohol without having to isolate the toxic boc-epoxide; high yield of pure enantiomorph
12/13/2001	US20010051657 Malonamic acids and derivatives thereof as thyroid receptor ligands
12/13/2001	CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	CA2410409A1 Antitumoral compounds
12/13/2001	CA2407644A1 Sulfonated perfluorovinyl functional monomers
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0889936B1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/11/2001	US6329449 Pulverulent rubber powders comprising modified fillers, processes for their preparation and their use
12/11/2001	US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
12/11/2001	US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal
12/11/2001	CA2203011C Herbicidal sulfonyl urea derivatives
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001	WO2001092217A2 Process for the preparation of amidostyrylstilbene-disulphonic acid compounds and novel amidostyrylstilbene-disulphonic acid compounds and their use as fluorescent whitening agents
12/06/2001	WO2001092213A2 Excitatory amino acid receptor modulators
12/06/2001	WO2001092210A1 Compounds for modulating the rage receptor
12/06/2001	WO2001092188A1 Method for labeling with tritium
12/06/2001	US20010049374 Amidino derivatives of quinoline and naphthalene
12/06/2001	DE10027025A1 Clycinamide Clycinamide
12/06/2001	DE10027024A1 Carbaminsäureester Carbamic
12/06/2001	CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001	CA2599562A1 Compounds for modulating the rage receptor
12/06/2001	CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001	EP1159278A2 Inhibitors of aspartyl protease
12/05/2001	EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001	EP1159263A1 Novel sulfonamide compounds and uses thereof
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1159260A1 Novel compounds and compositions as protease inhibitors
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	CN1325380A Benzene derivatives and medical use thereof
12/05/2001	CN1325376A Novel compounds and medicinal use thereof
12/05/2001	CN1325371A Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis
12/04/2001	US6326516 Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326393 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
11/2001
11/29/2001	WO2001090058A1 Nitrile compounds and process for their preparation
11/29/2001	WO2001090057A1 Sulfonamide derivatives
11/29/2001	WO2001090056A1 Sulfonamide derivatives
11/29/2001	WO2001090055A2 A process for preparing biphenyl compounds
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	US20010047110 Alkaline hydrogen peroxide to oxidize 2-cyano-2'-diaryl phosphinyl-1,1'-binaphthyl to obtain a 2-amido derivative, reacted with a metal alkoxide and bromine in an alcohol to a 2-sec-amino derivative; transition metal complex catalysts
11/29/2001	DE10025663A1 New arylacetic acid N-phenylamide or arylcarboxylic acid N-benzylamide derivatives, used as antithrombotic agents in treatment of e.g. deep leg vein thrombosis, are Factor Xa and thrombin inhibitors
11/29/2001	CA2409830A1 Sulfonamide derivatives
11/29/2001	CA2409829A1 Sulfonamide derivatives
11/29/2001	CA2409824A1 A process for preparing biphenyl compounds
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP0912089B1 Novel n-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/27/2001	US6323353 Complexes of transition metals with novel axial asymmetric compounds as the ligands
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087294A1 Phosphate transport inhibitors
11/22/2001	CA2408667A1 Phosphate transport inhibitors
11/21/2001	EP1156031A1 Novel compound, polymer prepared from the compound, and composition comprising the polymer
11/21/2001	EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001	EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001	EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/20/2001	US6319956 N1, n4-bis(cyclopropylmethylamino)trialkylenetetramines that may be toluenesulfonated.
11/20/2001	US6319946 Inhibitors of aspartyl protease
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials

1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 177